XML 32 R22.htm IDEA: XBRL DOCUMENT

Income Taxes	9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	14. Income Taxes For the three months ended September 30, 2020 and 2019, pre-tax losses were $16,641 and $33,172, respectively, and for the nine months ended September 30, 2020 and 2019, pre-tax losses were $70,935 and $78,412, respectively. The Company recognized a full tax valuation allowance against its deferred tax assets as of September 30, 2020 and December 31, 2019. The tax benefit related to the exercise of stock options is recognized as a deferred tax asset that is offset by a corresponding valuation allowance. The benefit from income taxes of $132 and $330 for the three months ended September 30, 2020 and 2019, respectively, and $436 and $650 for the nine months ended September 30, 2020 and 2019, respectively, relates to state R&D tax credits exchanged for cash pursuant to the Connecticut R&D Tax Credit Exchange Program, which permits qualified small businesses engaged in R&D activities within Connecticut to exchange their unused R&D tax credits for a cash amount equal to 65% of the value of the exchanged credits. On September 30, 2020 and December 31, 2019, the Company did not have any foreign subsidiaries and the international aspects of the Tax Cuts and Jobs Act are not applicable for the respective periods.

Income Taxes

9 Months Ended

Sep. 30, 2020

14. Income Taxes

For the three months ended September 30, 2020 and 2019, pre-tax losses were $16,641 and $33,172, respectively, and for the nine months ended September 30, 2020 and 2019, pre-tax losses were $70,935 and $78,412, respectively. The Company recognized a full tax valuation allowance against its deferred tax assets as of September 30, 2020 and December 31, 2019. The tax benefit related to the exercise of stock options is recognized as a deferred tax asset that is offset by a corresponding valuation allowance.

The benefit from income taxes of $132 and $330 for the three months ended September 30, 2020 and 2019, respectively, and $436 and $650 for the nine months ended September 30, 2020 and 2019, respectively, relates to state R&D tax credits exchanged for cash pursuant to the Connecticut R&D Tax Credit Exchange Program, which permits qualified small businesses engaged in R&D activities within Connecticut to exchange their unused R&D tax credits for a cash amount equal to 65% of the value of the exchanged credits.

On September 30, 2020 and December 31, 2019, the Company did not have any foreign subsidiaries and the international aspects of the Tax Cuts and Jobs Act are not applicable for the respective periods.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details